北京九强生物技术股份有限公司2025年半年度报告摘要

Group 1 - The company has approved a profit distribution plan, which includes a cash dividend of 3 yuan per 10 shares (including tax), with no bonus shares issued [2] - The company has not undergone any changes in its controlling shareholder or actual controller during the reporting period [4] - There are no preferred shareholders or related distributions during the reporting period [4] Group 2 - The company does not require retrospective adjustments or restatements of previous accounting data [3] - The company has confirmed that there are no changes in the number of shareholders or significant shareholders during the reporting period [3] - The company has no significant matters to report for the half-year period [4]